Atorvastatin 3-Deoxy-Hept-2-Enoic Acid Sodium Salt CAS 1105067-93-3(free base)
| CAS No. | 1105067-93-3(free base) |
| Molecular Formula | C33H32FN2O4 |
| Molecular Weight | N/A |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.
As a process- or degradation-related impurity, Atorvastatin 3-Deoxy-Hept-2-Enoic Acid Sodium Salt (CAS 1105067-93-3(free base), C33H32FN2O4Na) is essential for impurity profiling, related-substances testing, and forced-degradation studies in pharmaceutical development.
The molecular framework of Atorvastatin 3-Deoxy-Hept-2-Enoic Acid Sodium Salt (C33H32FN2O4Na) is characterized by a nitrogen-containing heterocyclic scaffold, an amide group, a hydroxyl group, an ether linkage, fluorine substitution. In reversed-phase chromatography, its retention is governed primarily by the protonation state of its nitrogen-containing groups, which provides a practical basis for HPLC-UV/DAD or LC-MS method development. Halogen substitution (F/Cl/Br/I) produces a distinctive isotope pattern in mass spectrometry, a valuable aid for qualitative confirmation.
The assigned purity is verified by mass-balance and quantitative NMR (qNMR) approaches, with the expanded uncertainty reported at a 95% confidence level (k=2). Batch homogeneity and stability are independently assessed for every lot.
Physical & Chemical Properties
| Molecular Formula | C33H32FN2O4 Na |
| Molecular Weight | 562.62 g/mol |
| Appearance | Pale yellow to yellow crystalline powder. (slight halide-like odor) |
| Purity | >80% |
| Storage | Store in a cool place (≤25°C), protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening; Contains ester bond; hydrolyzes under strong alkaline conditions |
| Degree of Unsaturation (DBE) | 18.5 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| Halogen Content | F-containing |
| Nitrogen Atoms | 2 |
Related Atorvastatin Standards
- Atorvastatin Impurity 22 (CAS 1035205-25-4)
- Atorvastatin Calcium Propylene Glycol Solvate (CAS 1040350-07-9)
- Atorvastatin Lactone Diepoxide (CAS 1046118-40-4)
- Atorvastatin Lactam calcium Salt Impurity (CAS 1046118-41-5)
- Atorvastatin Impurity 86 (CAS 1046118-44-8)
- Atorvastatin Impurity 141 Calcium Salt (CAS 1046378-58-8)
- Atorvastatin Impurity 76 (CAS 1099474-28-8)
- Atorvastatin EP Impurity F(Calcium Salt) (CAS 1105067-87-5)
Recommended Standards
- Folic Acid EP Impurity E Sulfate (CAS CATO-C4X-139541)
- Salmeterol Impurity 23 (CAS CATO-C4X-105023)
- Eltrombopag Impurity 17 (CAS 18048-64-1)
- 1-(3-Fluorophenyl)-5-(thiophen-3-yl)-1H-pyrazole (CAS 1269291-21-5)
- Concanamycin C (CAS 81552-34-3)
- 1-Amino-2-methyl-1-(pyridin-3-yl)propan-2-ol (CAS 58644-88-5)
- 5,10,15,20-Tetra (1-methyl-4-pyridyl) porphyrin copper (CAS 48242-70-2)
- 5-Methyl-2-((trifluoromethyl)sulfonyl)aniline (CAS 1466714-66-8)
- 2-((2-Aminoethyl)amino)-5-nitrobenzonitrile (CAS 926244-53-3)
- Ephrin-A2-Selective YSA-Peptide (CAS 532441-10-4)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com